Shashank Upadhye has joined the litigation department of Seyfarth Shaw LLP in the intellectual property practice as a partner in Chicago. His practice includes pharmaceutical patent litigation, Hatch-Waxman law as it relates to generic and branded pharmaceutical companies and Federal Drug Administration regulatory law. He has extensive experience working on both the brand and generic sides at pharmaceutical companies, and he has advised and served as a consultant to businesses, financiers and government agencies. Upadhye joins the firm from Apotex, Inc., a Toronto-based global pharmaceutical company, where he was vice president and global head of intellectual property. Prior to his position at Apotex, Upadhye was vice president - head of IP (U.S.) at a division of Novartis. Upadhye received his Bachelor's degrees from Brock University, his law degree from the New England School of Law and his Master of Law degree in Intellectual Property Law from John Marshall Law School.
Copyright © 2017, Los Angeles Times
- Crime, Law and Justice
- Pharmaceutical Industry
- Chemical Industry
- Patents, Copyrights and Trademarks